Vincristine, dactinomycin, cyclophosphamide (VAC) versus VAC/V plus irinotecan (VI) for intermediate-risk rhabdomyosarcoma (IRRMS): A report from the Children's Oncology Group Soft Tissue Sarcoma Committee Meeting Abstract


Authors: Hawkins, D. S.; Anderson, J. R.; Mascarenhas, L.; McCowage, G. B.; Rodeberg, D. A.; Wolden, S. L.; Parham, D.; Million, L.; Donaldson, S. S.; Hayes-Jordan, A. A.; Brown, K. L. B.; Teot, L. A.; Spunt, S. L.; Meyer, W. H.
Abstract Title: Vincristine, dactinomycin, cyclophosphamide (VAC) versus VAC/V plus irinotecan (VI) for intermediate-risk rhabdomyosarcoma (IRRMS): A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613204543
PROVIDER: wos
Notes: Meeting Abstract: 10004 -- Source: Wos